Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Sommaggio

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Molecular Cell|December 3, 2014
Mutant p53 reprograms TNF signaling in cancer cells through interaction with the tumor suppressor DAB2IPGiulio Di Minin, Arianna Bellazzo, Marco Dal Ferro, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 19, 2025
Highlighting recent achievements to advance more effective cancer immunotherapyBeatrice Belmonte, Sheila Spada, Paola Allavena, et al.
Journal for Immunotherapy of Cancer|July 17, 2021
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cellsAnna Dalla Pietà, Elisa Cappuzzello, Pierangela Palmerini, et al.
EMBO Molecular Medicine|December 21, 2013
Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breastAlessandra Rustighi, Alessandro Zannini, Luca Tiberi, et al.
Nature Cell Biology|June 28, 2016
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancerDawid Walerych, Kamil Lisek, Roberta Sommaggio, et al.
Journal for Immunotherapy of Cancer|December 17, 2025
CD300e is a driver of the immunosuppressive tumor microenvironment and colorectal cancer progression via macrophage reprogrammingAnnica Barizza, Stefania Vassallo, Laura Masatti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 31, 2025
On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccineAnna Dalla Pietà, Beatrice Genova, Alessandro Penna, et al.
Nature Communications|August 10, 2020
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretomeValeria Capaci, Lorenzo Bascetta, Marco Fantuz, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Molecular Cell|December 3, 2014
Mutant p53 reprograms TNF signaling in cancer cells through interaction with the tumor suppressor DAB2IPGiulio Di Minin, Arianna Bellazzo, Marco Dal Ferro, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 19, 2025
Highlighting recent achievements to advance more effective cancer immunotherapyBeatrice Belmonte, Sheila Spada, Paola Allavena, et al.
Journal for Immunotherapy of Cancer|July 17, 2021
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cellsAnna Dalla Pietà, Elisa Cappuzzello, Pierangela Palmerini, et al.
EMBO Molecular Medicine|December 21, 2013
Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breastAlessandra Rustighi, Alessandro Zannini, Luca Tiberi, et al.
Nature Cell Biology|June 28, 2016
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancerDawid Walerych, Kamil Lisek, Roberta Sommaggio, et al.
Journal for Immunotherapy of Cancer|December 17, 2025
CD300e is a driver of the immunosuppressive tumor microenvironment and colorectal cancer progression via macrophage reprogrammingAnnica Barizza, Stefania Vassallo, Laura Masatti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 31, 2025
On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccineAnna Dalla Pietà, Beatrice Genova, Alessandro Penna, et al.
Nature Communications|August 10, 2020
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretomeValeria Capaci, Lorenzo Bascetta, Marco Fantuz, et al.
Pageof 3